Immediate Impact
42 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Extracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors
2024 Standout
Works of Aleš Rozman being referenced
Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study
2022
Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aleš Rozman | 249 | 62 | 25 | 39 | 26 | 306 | |
| Federico Mei | 218 | 51 | 14 | 35 | 35 | 287 | |
| Saurabh Kumar Singh | 231 | 83 | 22 | 21 | 28 | 345 | |
| Ping‐Chia Cheng | 221 | 59 | 34 | 9 | 24 | 324 | |
| R Kobayashi | 310 | 189 | 16 | 14 | 28 | 365 | |
| Patrizia Ruggiero | 205 | 53 | 5 | 24 | 22 | 342 | |
| Chi‐Der Chiang | 149 | 57 | 23 | 66 | 22 | 294 | |
| Nicol Bernardinello | 240 | 20 | 51 | 27 | 41 | 352 | |
| Francesco Sollitto | 233 | 132 | 21 | 13 | 32 | 359 | |
| Van K. Holden | 166 | 58 | 81 | 7 | 36 | 276 | |
| E Struve-Christensen | 192 | 144 | 4 | 12 | 24 | 312 |
All Works
Login with ORCID to disown or claim papers
Loading papers...